Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Genitourinary System Carcinoma”

2,433 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 2,433 results

Testing effectiveness (Phase 2)UnknownNCT03013712
What this trial is testing

A Clinical Research of CAR T Cells Targeting EpCAM Positive Cancer

Who this might be right for
Colon CancerEsophageal CarcinomaPancreatic Cancer+3 more
First Affiliated Hospital of Chengdu Medical College 60
Early research (Phase 1)Study completedNCT00739453
What this trial is testing

Dose-escalation Study of OSI-906 and Erlotinib (Tarceva®)

Who this might be right for
Advanced Solid Tumors
Astellas Pharma Inc 95
Early research (Phase 1)Study completedNCT00056537
What this trial is testing

ABR-217620 in Patients With Advanced Non-Small Cell Lung Cancer, Renal Clear Cell Carcinoma or Pancreatic Cancer

Who this might be right for
Non-Small-Cell Lung CarcinomaRenal Cell CarcinomaPancreatic Cancer
Active Biotech AB 44
Early research (Phase 1)Study completedNCT02897375
What this trial is testing

Palbociclib With Cisplatin or Carboplatin in Advanced Solid Tumors

Who this might be right for
Solid NeoplasmStage III Pancreatic CancerStage IIIA Breast Cancer+14 more
Emory University 71
Not applicableUnknownNCT03221335
What this trial is testing

EUS-guided RFA for Solid Abdominal Neoplasms

Who this might be right for
Digestive System Neoplasms
Chinese University of Hong Kong 30
Large-scale testing (Phase 3)Study completedNCT00005590
What this trial is testing

Levofloxacin to Prevent Infection Following Chemotherapy in Treating Patients With Solid Tumors or Lymphoma

Who this might be right for
Brain and Central Nervous System TumorsBreast CancerExtragonadal Germ Cell Tumor+7 more
Cancer Research Campaign Clinical Trials Centre
Early research (Phase 1)Active Not RecruitingNCT02627443
What this trial is testing

Carboplatin, Gemcitabine Hydrochloride, and Berzosertib in Treating Patients With Recurrent and Metastatic Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

Who this might be right for
Metastatic Fallopian Tube CarcinomaMetastatic Ovarian CarcinomaMetastatic Primary Peritoneal Carcinoma+9 more
National Cancer Institute (NCI) 35
Not applicableLooking for participantsNCT06804135
What this trial is testing

Systemic and Tumor Immune Response During Pelvic (Chemo)Radiation and/or Brachytherapy for Cervical Cancer

Who this might be right for
Cervical Carcinoma
Tata Memorial Hospital 110
Testing effectiveness (Phase 2)Looking for participantsNCT06412510
What this trial is testing

Prehabilitation for EOC, Fallopian Tube, Primary Peritoneal Carcinoma and Pancreatic Cancer w/ NACT

Who this might be right for
Ovarian CancerEpithelial Ovarian CancerPancreatic Adenocarcinoma
Case Comprehensive Cancer Center 22
Testing effectiveness (Phase 2)Study completedNCT00453310
What this trial is testing

Sunitinib in Treating Patients With Metastatic Germ Cell Tumors That Have Relapsed or Not Responded to Treatment

Who this might be right for
Extragonadal Germ Cell TumorOvarian CancerTeratoma+1 more
Memorial Sloan Kettering Cancer Center 10
Testing effectiveness (Phase 2)Study completedNCT00101348
What this trial is testing

Erlotinib and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic or Unresectable Kidney, Colorectal, Head and Neck, Pancreatic, or Non-Small Cell Lung Cancer

Who this might be right for
Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell CarcinomaRecurrent Adenoid Cystic Carcinoma of the Oral CavityRecurrent Basal Cell Carcinoma of the Lip+64 more
National Cancer Institute (NCI) 66
Testing effectiveness (Phase 2)Study completedNCT03562897
What this trial is testing

Evaluation of Ocoxin-Viusid® in Advanced or Metastatic Ovarian Epithelial Cancer

Who this might be right for
CarcinomaOvarian NeoplasmEndocrine Gland Neoplasm+10 more
Catalysis SL 40
Early research (Phase 1)Ended earlyNCT06457997
What this trial is testing

PHN-010 in Patients With Advanced Solid Tumors

Who this might be right for
Lung CancerColon CancerEndometrial Cancer+4 more
Pheon Therapeutics 26
Early research (Phase 1)Study completedNCT03811652
What this trial is testing

A Multiple Ascending Dose Study of MEDI7247 in Advanced or Metastatic Solid Tumors

Who this might be right for
Non Small Cell Lung Cancer Squamous (NSCLC-Sq)Head and Neck Squamous Cell Carcinoma (HNSCC)Small Cell Lung Cancer (SCLC)+3 more
MedImmune LLC 8
Early research (Phase 1)Looking for participantsNCT06307925
What this trial is testing

A Phase I Study to Evaluate the Safety, Pharmacokinetics and Antitumor Activity of HC010 in Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumor
HC Biopharma Inc. 122
Early research (Phase 1)UnknownNCT05420545
What this trial is testing

A Clinical Study of CD70-targeted CAR-T in the Treatment of CD70-positive Advanced/Metastatic Solid Tumors

Who this might be right for
Metastatic TumorAdvanced Solid TumorRenal Cell Carcinoma+2 more
Chongqing Precision Biotech Co., Ltd 36
Testing effectiveness (Phase 2)UnknownNCT02595021
What this trial is testing

Total/Subtotal Colectomy in Ovarian Cancer

Who this might be right for
Epithelial Ovarian CancerFallopian Tube CancerPrimary Peritoneal Carcinoma+1 more
Shanghai Gynecologic Oncology Group 80
Large-scale testing (Phase 3)Study completedNCT00003214
What this trial is testing

Chemosensitivity Testing to Assign Treatment for Patients With Stage III or Stage IV Ovarian Cancer

Who this might be right for
Ovarian Cancer
Swiss Cancer Institute 300
Early research (Phase 1)Study completedNCT00514306
What this trial is testing

Study of Intermittent OSI-906 Dosing

Who this might be right for
Advanced Solid Tumors
Astellas Pharma Inc 79
Early research (Phase 1)Ended earlyNCT05317078
What this trial is testing

Safety, Tolerability, and Pharmacokinetics Study of AMG 794 With Claudin 6-positive Non-small Cell Lung Cancer, Epithelial Ovarian Cancer, and Other Malignant Solid Tumor Indications

Who this might be right for
Non-squamous Non-small Cell Lung CancerEpithelial Ovarian CancerClaudin 6-positive Advanced/Metastatic Malignant Solid Tumors
Amgen 3
Load More Results